NCT06793540 Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
| NCT ID | NCT06793540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Stone, Kidney |
| Study Type | INTERVENTIONAL |
| Enrollment | 216 participants |
| Start Date | 2025-06-30 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 216 participants in total. It began in 2025-06-30 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this study is to evaluate the effectiveness of an auto posturotherapy technique on the RFS at three months of patients treated for lower calyceal urinary stones by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy.
Eligibility Criteria
pré Inclusion Criteria: * Patient having read and signed the consent form for participation in the study • Patient candidate for an intervention on a lower calyx stone \<15mm by LEC or URSS Patients meeting all of the following criteria may be definitively included in the study: * Patient treated by LEC, or patient treated by URSS and for whom the presence of lower calyceal fragments has been observed by endoscopy * Absence of JJ stent (patients for whom a JJ stent was implanted after URSS or before LEC may be included as soon as it is removed) Exclusion Criteria: * Patients presenting one of the following criteria will not be included in the study: * Renal or ureteral malformation: ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, para calyceal diverticulum, pelvic kidney. * LEC session interrupted due to treatment intolerance * Physical disability making posturotherapy impossible (particularly spinal, etc.), morbid obesity, major gastroesophageal reflux, heart or respiratory failure. * Balance disorder which would not allow self-posturotherapy to be carried out alone. * Patient under legal protection, under guardianship or under curatorship * Posturotherapy carried out while wearing a JJ probe * Posturotherapy carried out by a third party (physiotherapist or other) * Pregnant or breastfeeding patient * Patient not affiliated to the French social security system * Impossibility of providing the subject with informed information and/or giving written informed consent: dementia, psychosis, disorders of consciousness, non-French speaking patient * Treatment that may modify the clearance of fragments (beta blocker, diuretic, etc.) * Patient included in another therapeutic study protocol
Frequently Asked Questions
Who can join the NCT06793540 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Stone, Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793540 currently recruiting?
Yes, NCT06793540 is actively recruiting participants. Visit ClinicalTrials.gov or contact GCS Ramsay Santé pour l'Enseignement et la Recherche to inquire about joining.
Where is the NCT06793540 trial being conducted?
This trial is being conducted at Lyon, France, Quint-Fonsegrives, France.
Who is sponsoring the NCT06793540 clinical trial?
NCT06793540 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 216 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.